Hibridinės laboratorijos - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 2,000 | 3,000 | 500 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 |
| Profit before tax | -347 | 643 | -1,285 | 454 | 95 | -217 | 376 | 378 |
| Net profit | -347 | 643 | -1,285 | 454 | 95 | -217 | 376 | 378 |
| Equity | 890 | 1,533 | 246 | 700 | 795 | 577 | 954 | 1,332 |
| Liabilities | 109 | 0 | 189 | 0 | 29 | 58 | 75 | 176 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current assets | 999 | 1,533 | 435 | 700 | 824 | 635 | 1,029 | 1,508 |
| Total assets | 999 | 1,533 | 435 | 700 | 824 | 635 | 1,029 | 1,508 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 235 | 224 | 224 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -33.3% | +50.0% | -83.3% | +500.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -34.7% | 41.9% | -295.4% | 64.9% | 11.5% | -34.2% | 36.5% | 25.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -39.0% | 41.9% | -522.4% | 64.9% | 11.9% | -37.6% | 39.4% | 28.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -17.4% | 21.4% | -257.0% | 15.1% | 3.2% | -7.2% | 12.5% | 12.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -17.4% | 21.4% | -257.0% | 15.1% | 3.2% | -7.2% | 12.5% | 12.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | - | 0.8 | - | 0.0 | 0.1 | 0.1 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 1,000 | 1,500 | 250 | 2,769 | 3,000 | 3,000 | 3,000 | 3,000 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Hibridinės laboratorijos - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2021-11-16 | 2021-11-29 | 0.01 |
| 2021-10-18 | 2021-11-02 | 0.01 |
Hibridinės laboratorijos - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Hibridines laboratorijos, UAB (company code 303395413) is a private limited liability company engaged in business and other management consultancy activities. In 2025, the latest financial year, revenue remained stable at €3.0K, while net profit was €378, resulting in a profit margin of 12.6%. This followed a loss of €217 in 2023 and a return to profitability in 2024 with net profit of €376, showing a clear improvement in operating performance over the 2023–2025 period. The balance sheet also expanded gradually: total assets increased from €635 in 2023 to €1.5K in 2025, while equity rose from €577 to €1.3K. Liabilities stayed low but increased from €58 to €176 over the same period. Key ratios for 2025 indicate a strong equity position, with an equity ratio of 88.3% and debt-to-equity of 0.13. Asset turnover was 1.99x, and return on equity and return on assets were 28.4% and 25.1%, respectively. Revenue per employee in 2025 was €3.0K, with profit per employee of €378.